| Patents for A61P 37 - Drugs for immunological or allergic disorders (117,141) |
|---|
| 03/04/2004 | WO2004018434A1 Pyrimidine compounds |
| 03/04/2004 | WO2004018431A2 Novel phenanthridines |
| 03/04/2004 | WO2004018425A1 N-4-piperidinyl compounds as ccr5 modulators |
| 03/04/2004 | WO2004018412A1 Crystalline solid form of (2s-5z)-2-amino-7-(ethanimidoylamino)-2-methylhept-5-enoic acid |
| 03/04/2004 | WO2004018058A2 Compounds, compositions, and methods |
| 03/04/2004 | WO2004018043A1 A pharmaceutical preparation containing palladium complex compounds and the uses thereof for treating cancer and autoimmune disease |
| 03/04/2004 | WO2004017970A1 Piperidin-2,6-dione pamoate salts and their use for the treatment of stress-related affective disorders |
| 03/04/2004 | WO2004017966A1 Five-membered heterocyclic compounds in the treatment of chronic and acute pain |
| 03/04/2004 | WO2004017965A1 1,3-thiazolin-4-ones as therapeutic compounds in the treatment of pain |
| 03/04/2004 | WO2004017950A2 Phosphadidylinositol 3,5-biphosphate inhibitors as anti-viral agents |
| 03/04/2004 | WO2004017948A2 Use of lck inhibitor for treatment of immunologic diseases |
| 03/04/2004 | WO2004017920A2 Novel biphenyl and biphenyl-like cannabinoids |
| 03/04/2004 | WO2004017810A2 Tumor specific oligosaccharide epitopes and use thereof |
| 03/04/2004 | WO2003106456A3 Azabicyclo-octane and nonane derivatives with ddp-iv inhibiting activity |
| 03/04/2004 | WO2003105908A9 Methods and compositions using cellular asialodeterminants and glycoconjugates for targeting cells to tissues and organs |
| 03/04/2004 | WO2003083089A3 Tolerogenic antigen-presenting cells |
| 03/04/2004 | WO2003068822A3 De-immunized (poly)peptide constructs |
| 03/04/2004 | WO2003060082A3 Use of modified pyrimidine compounds to promote stem cell migration and proliferation |
| 03/04/2004 | WO2003059276A3 Novel mammalian multipotent stem cells and compositions, methods of preparation and methods of administration thereof |
| 03/04/2004 | WO2003055980A3 Il-17 like molecules and uses thereof |
| 03/04/2004 | WO2003051365A3 Use of compounds of the benzamide family as immunosuppressant |
| 03/04/2004 | WO2003050067A3 Vitamin d analogues |
| 03/04/2004 | WO2003024928A3 Novel aminoazetidine, -pyrrolidine and -piperidine derivatives |
| 03/04/2004 | WO2003000846A3 A novel g protein-coupled receptor, gave 3 |
| 03/04/2004 | WO2003000310A9 Nasal devices |
| 03/04/2004 | WO2002096867A3 Inhibitors of protein kinase for the treatment of disease |
| 03/04/2004 | WO2002094178A3 Treatment of renal fibrosis |
| 03/04/2004 | WO2002092762A3 Cytokine polypeptides |
| 03/04/2004 | WO2002085944A3 Single chain camelid vhh antibodies, method for their production in a mammal and their uses |
| 03/04/2004 | WO2002020762A8 Tnf receptor-like molecules and uses thereof |
| 03/04/2004 | WO2002012502A9 Anti-tnf antibodies, compositions, methods and uses |
| 03/04/2004 | US20040044213 Process for making substituted 8-arylquinolinium benzenesulfonate |
| 03/04/2004 | US20040044212 (Dihydro) Isoquinoline derivatives as phosphodiesterase inhibitors |
| 03/04/2004 | US20040044199 Cyclic urea compounds and preparation thereof |
| 03/04/2004 | US20040044194 Aggrecanase molecules |
| 03/04/2004 | US20040044188 Identifying peptide mimetic for treatment and prevention of tumors and autoimune diseases |
| 03/04/2004 | US20040044061 Analgesics; side effect reduction |
| 03/04/2004 | US20040044051 Cannabinoid receptor agonists |
| 03/04/2004 | US20040044050 Antiinflammatory agents; cardiovascular disorders; vision disorders; skin disorders; central nervous system disorders; antiarthritic agents |
| 03/04/2004 | US20040044038 Polymorphic form XVI of fexofenadine hydrochloride |
| 03/04/2004 | US20040044036 Piperidine derivatives and drugs containing these derivatives as active ingredient |
| 03/04/2004 | US20040044035 Antiallergens; rhinitis |
| 03/04/2004 | US20040044034 Tyrosine kinase inhibitor; anticancer agents; antiproliferative agents |
| 03/04/2004 | US20040044027 Induce immunology response; central nervous system disorders;sleep disorders; gastrointestinal disorders |
| 03/04/2004 | US20040044018 Methods and pharmaceutical compositions for treatment of central and peripheral nervous system disorders and compounds useful therefor |
| 03/04/2004 | US20040044013 Antiarthritic agents; side effect reduction |
| 03/04/2004 | US20040044002 Kinase inhibitors; antiproliferative agents; antiinflammatory agents; autoimmune diseases; skin disorders; anticancer agents; antiproliferative agents |
| 03/04/2004 | US20040043999 Phthalazine derivatives as phosphodiesterase 4-inhibitors |
| 03/04/2004 | US20040043991 Antiarthritic agents; anticancer agents; antiinflammatory agents |
| 03/04/2004 | US20040043972 Autoimmune disease; antidiabetic agents |
| 03/04/2004 | US20040043935 Synthetic immunogenic but non amyloidogenic peptides homologous to amyloid beta for induction of an immune response to amyloid beta and amyloid deposits |
| 03/04/2004 | US20040043929 Novel proteins and nucleic acids encoding same |
| 03/04/2004 | US20040043926 Comprises polypeptides for diagnosing, treating and preventing cardiomyopathy, atherosclerosis and cancer |
| 03/04/2004 | US20040043918 Containing phosphatides; killing cancer, tumor cells |
| 03/04/2004 | US20040043411 DSP-11 dual-specificity phosphatase |
| 03/04/2004 | US20040043402 Interferon-alpha induced gene |
| 03/04/2004 | US20040043391 Leptospira vaccine antigens for the prevention of Leptospirosis |
| 03/04/2004 | US20040043039 Method for inducing an immune response to polysaccharide bacterial antigens and to protein structures of virus capsides |
| 03/04/2004 | US20040043038 Vaccines |
| 03/04/2004 | US20040043032 Vaccine |
| 03/04/2004 | US20040043018 Adjust concentration of interleukins |
| 03/04/2004 | US20040043008 Dissociation muscle tissues; culturing; accumulation |
| 03/04/2004 | US20040043002 Polyol-IFN-beta conjugate and composition containing same |
| 03/04/2004 | DE10238045A1 2-Thio-substituierte Imidazolderivate und ihre Verwendung in der Pharmazie 2-thio-substituted imidazole derivatives and their use in the pharmaceutical |
| 03/04/2004 | CA2501849A1 2-thio-substituted imidazole derivatives and their use in treating diseases associated with a disorder of the immune system |
| 03/04/2004 | CA2496686A1 A pharmaceutical preparation containing palladium complex compounds and the uses thereof for treating cancer and autoimmune disease |
| 03/04/2004 | CA2496242A1 T-cell epitopes in staphylococcal enterotoxin b |
| 03/04/2004 | CA2495903A1 Novel biphenyl and biphenyl-like cannabinoids |
| 03/04/2004 | CA2495597A1 Novel phenanthridines |
| 03/04/2004 | CA2495377A1 Piperidin-2,6-dione pamoate salts and their use for the treatment of stress-related affective disorders |
| 03/04/2004 | CA2494974A1 Il-7 drug substance, composition, preparation and uses |
| 03/04/2004 | CA2494650A1 Pyridazinone-derivatives as pde4 inhibitors |
| 03/03/2004 | EP1394184A1 Apoptose inhibitor |
| 03/03/2004 | EP1394175A1 Inhibitors of interleukin-1beta converting enzyme |
| 03/03/2004 | EP1394147A1 Carboxylic acid derivative and medicine comprising salt or ester of the same |
| 03/03/2004 | EP1393750A2 Conjugates for treating an immune disease |
| 03/03/2004 | EP1393744A1 Acellular pertussis vaccines and methods of preparation thereof |
| 03/03/2004 | EP1392852A2 Nucleic acid-associated proteins |
| 03/03/2004 | EP1392845A2 A g-protein coupled receptor and uses therefor |
| 03/03/2004 | EP1392844A2 Use of hmg fragments as anti-inflammatory agents |
| 03/03/2004 | EP1392734A1 Hevein-binding monoclonal antibodies |
| 03/03/2004 | EP1392733A2 Mammalian tumor susceptibility gene products and their uses |
| 03/03/2004 | EP1392713A2 Liver x receptor agonists |
| 03/03/2004 | EP1392694A1 Optical resolution of (1-benzyl-4-methylpiperidin-3-yl)-methylamine and the use thereof for the preparation of pyrrolo[2,3]pyrimidine derivatives as protein kinases inhibitors |
| 03/03/2004 | EP1392683A1 SUBSTITUTED 4 i H /i -CHROMENES AND ANALOGS AS ACTIVATORS OFGASP ASES AND INDUCERS OF APOPTOSIS AND THE USE THEREOF |
| 03/03/2004 | EP1392680A2 Selective anthranilamide pyridine amides as inhibitors of vegfr-2 and vegfr-3 |
| 03/03/2004 | EP1392662A1 Cdk inhibiting pyrimidines, production thereof and their use as medicaments |
| 03/03/2004 | EP1392661A1 Diarylurea derivatives useful as anti-inflammatory agents |
| 03/03/2004 | EP1392648A1 Hydroxamic acids and acyl hydroxamines as naaladase inhibitors |
| 03/03/2004 | EP1392642A2 Novel compounds as anti-inflammatory, immunomodulatory and anti-proliferatory agents |
| 03/03/2004 | EP1392641A1 Substituted cyclohexane-1,4-diamine derivatives |
| 03/03/2004 | EP1392623A1 Production and use of a polar lipid-rich fraction containing omega-3 and/or omega-6 highly unsatruated fatty acids from microbes, genetically modified plant seeds and marine organisms |
| 03/03/2004 | EP1392389A2 Microprojection array having a beneficial agent containing coating |
| 03/03/2004 | EP1392366A1 Nuclear receptor-mediated introduction of a pna into cell nuclei |
| 03/03/2004 | EP1392365A2 Compositions and therapeutical use of polynucleotides encoding tcrs |
| 03/03/2004 | EP1392351A2 Chemokines as adjuvants of immune response |
| 03/03/2004 | EP1392336A1 Korean acanthopanax senticosus extract, protein extract, crude protein-polysaccharide which were extracted from korean acanthopanax senticosus, and immunoregulating compositions comprising the same and use thereof |
| 03/03/2004 | EP1392330A1 Use of lps for treating intestinal inflammation processes |
| 03/03/2004 | EP1392327A2 Use of azithromycin for the manufacture of a medicament for treatment of non-infective inflammatory diseases |
| 03/03/2004 | EP1392323A2 Use of a vitamin d3 analogue for the treatment of autoimmune diabetes |